Colon cancer: take 5 minutes to detect
Among people 50 and older, screening for colon cancer, based on the research of occult blood in the stool, even before the appearance of any digestive symptom, is an asset. It can detect precancerous lesions and treat them, then giving all the chances of recovery for the patient. With 42,000 new cases per year, colorectal cancer is, both sexes at 3 th among the most common cancers: 2nd in women and the third among men . It occurs mostly in the elderly over 50 years. “According to estimates, the number of colorectal cancers is expected to reach 45,000 new cases annually in 2020,” laments INCa.
A new test based on an immunological technique is now available to people aged 50 to 74, every 2 years, as part of organized screening. The number of tests each week increased in spring 2016 but a summer decline occurred. Taking advantage of the fall period conducive to medical consultations, the Inca, in partnership with the Ministry of Health, launched in November 2016 an information device on organized colorectal cancer screening. This device complements the campaign usually released in March and now recognizable blue ribbon. The campaign recalls the major issue of screening, “2 e deadliest cancer” and earnings: detected early, colorectal cancer is cured in 9 cases out of 10 . It concluded on the need to broach the subject with her doctor from the age of 50 years.
Since June 2015, in the west of Paris, the Ambroise Paré Hospital (AP-HP) and René Huguenin of the Institut Curie are pooling their skills and resources to identify and treat patients with digestive cancers, including colorectal cancers, covering all areas of support.
>> The Ambroise Paré Hospital (Boulogne-Billancourt) provides endoscopic screening which occurs after the immunoassay for the diagnosis, the e-surgical treatment of digestive tumors, adapting therapeutic strategies for elderly and diagnostic radiology and Interventional.
>> The René Huguenin-hospital (St. Cloud) provides nuclear imaging and supports patients for treatment with radiotherapy and chemotherapy on more advanced platforms and using protocols that include the latest findings of targeted therapies without mention access to immunotherapy. The Institut Curie is a reference center in Oncogenetics (detection and management).
Since November 2015, the Institut Curie provides consultation “outside the walls” at the Ambroise Pare hospital. “This sharing of skills and this effective complementarity are pledges of better care for patients,” said Dr. Wulfran Cacheux gastrointestinal oncologist and physician responsible in the management of digestive cancers at the Institut Curie. “This structured pathway between our hospitals has already helped to support more than 300 patients and perform more than 2,000 consultations since the establishment of this collaboration. It provides rapid response and appointments coordinated between two hospitals. “